NSCLC Immunotherapy: A New Hope

Created by the Society for Immunotherapy of Cancer (SITC), "Non-small Cell Lung Cancer Immunotherapy: A New Hope" follows a patient's journey from her diagnosis of NSCLC through the process of learning about cancer immunology, leading to her consideration of cancer immunotherapy treatments via clinical trial participation. This video provides patients with easy to understand and unbiased information on how cancer immunotherapy works, as well as informative discussion regarding cancer immunotherapy clinical trials for patients with NSCLC. This video was produced prior to the 2015 US FDA approvals of Opdivo® (nivolumab) for the treatment of squamous and non-squamous non-small cell lung cancer and Keytruda® (pembrolizumab) for the treatment of non-small cell lung cancer in patients whose tumors express PD-L1. More educational resources will be developed in this area as advancements in the field continue. Watched this video? Now watch NSCLC Immunotherapy: Advancing Hope™ https://www.youtube.com/watch?v=jCABa6bYoZ8